Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America: Volume 52-3

Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America Volume 52-3In this issue of Endocrinology and Metabolism Clinics of North America, guest editors Drs.\n\nSherouk Fouda and Joseph M. Pappachan bring their considerable expertise to the topic of Metabolic Associated Fatty Liver Disease. Top experts address the various ways metabolic associated fatty liver disease is related to other conditions such as diabetes, sarcopenia, PCOS, and more, as well as the management of MAFLD and cardiovascular implications.Contains 12 practice-oriented topics including obstructive sleep apnea and MAFLD; the interlink between MAFLD and polycystic ovary syndrome; pregnancy and MAFLD; MAFLD and gut microbiota; and more.Provides in-depth clinical reviews of metabolic associated fatty liver disease, offering actionable insights for clinical practice.Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America: Volume 52-3 1st Edition is written by Joseph M. Pappachan; Sherouk Fouda and published by Elsevier. ISBNs for Metabolic-associated fatty liver disease, An Issue of Endocrinology and Metabolism Clinics of North America are 9780443184086, 0443184089 and the print ISBNs are 9780443184079, 0443184070.